Kogulugu

Medicinal Products Act Amendment Act ↗

Introduced:
23 September 2024
Author:
Government · coalition at introduction: Reform, Eesti 200, SDE
Stage
Second reading

The draft gives the holder of a hospital pharmacy service licence the right to import medicines and active substances. According to the explanatory memorandum, the aim is to make it more flexible for hospital pharmacies to improve medicine availability and plan spending on medicines. Import-related duties are added for the pharmacy and its responsible person.

Changes and additions

  1. Hospital pharmacy import right

    The holder of a hospital pharmacy service licence may import medicines and active substances for the task set out in section 30(4) of the Medicinal Products Act (Ravimiseadus): supplying its own hospital and, by agreement, other hospitals, care institutions and ambulance providers.
  2. Responsible person's duty on import

    According to the memorandum, a similar duty applies to the responsible person of a wholesale licence holder. It did not apply to a hospital pharmacy's responsible person.
    When a wholesale or hospital pharmacy licence holder imports medicines, the responsible person (pädev isik) must check that storage conditions were observed in transport and that the packaging is proper and matches the marketing authorisation.
  3. Reference to EU directive

    A reference to Directive (EU) 2015/1535, on the procedure for notifying technical regulations, is added to the Act's technical note.

How the text changed during the proceedings

  • Since introduction, the only change in the draft text is a note that the lead committee is the Social Affairs Committee (sotsiaalkomisjon).

Votes

No votes have been held yet.

Sources (Riigikogu documents) (11)

Official page of the bill on the Riigikogu website: proceedings and all documents.